Persistence Targeted Smoking Cessation in Schizophrenia (NIDA R21/R33)
PI: Marc L. Steinberg, Ph.D. Co-Investigators: Jill M. Williams, MD, Shou-En Lu, Ph.D.
- The R21 portion of this study will included modifying an existing psychosocial treatment for smokers with schizophrenia and conducting an open pilot (N=26) testing the ability of this new intervention (“Persistence Targeted Smoking Cessation in Schizophrenia (PTSC-S)”) to increase task persistence in smokers with schizophrenia.
- The R33 portion of this study, modified from the original due to COVID-19, is an acceptability and feasibility study of the PTSC-S intervention delievered via telehealth to smokers with Schizophrenia, Schizoaffective Disorder, and Bipolar Disorder.
The current flyer for this study can be downloaded HERE.